Skip to main content
Erschienen in:

06.05.2020 | Original Article

A systematic review and meta-analysis of the clinical outcomes of TAVI versus SAVR in the octogenarian population

verfasst von: Stuart Moss, Mathew Doyle, Vinayak Nagaraja, Sheen Peeceeyen

Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Surgical aortic valve replacement (SAVR) has shown safe, robust results in elderly populations, and up until recently, was the gold standard for management of severe aortic stenosis. The approach to severe aortic stenosis in high-risk populations, such as octogenarians, has been challenged with the development of transcatheter-based strategies. We sought to systematically analyse outcomes between surgical and transcatheter aortic valve replacement (TAVI) in octogenarians.

Method

Electronic databases were searched from their inception until November 2018 for studies comparing SAVR to TAVI in octogenarians, according to a predefined search criterion. The primary end point was mortality, and secondary end points included post-procedural complications.

Results

The review yielded four observational studies. The total number of patients included was 1221 including 395 who underwent TAVI and 826 SAVR. On average, patients from both subgroups carried a high number of cardiac risk factors, and STS-PROM scoring yielded mean values equating to high-risk population groups, with significantly higher values for TAVI patients across the board. The presence of post-procedural moderate aortic regurgitation was noted only in the TAVI population (OR = 8.88; 95% CI (1.47–53.64), χ2 = 1.22; p = 0.02; I2 = 0%). Otherwise, there were no significant differences when accounting for mortality (OR = 0.68; 95% CI (0.44–1.05), χ2 = 1.88; p = 0.60; I2 = 0%), permanent pacemaker implantation groups (OR = 0.45; 95% CI (0.44–1.49), χ2 = 0.11; p = 0.19; I2 = 0%), and neurological events (OR = 0.72; 95% CI (0.42–1.23), χ2 = 2.57; p = 0.23; I2 = 22%).

Discussion

The analysed data on TAVI versus SAVR in the octogenarian population show that TAVI shows similar outcomes with relation to mortality and inpatient admission times, in a population with significantly higher risk profiles than their SAVR counterparts. TAVI has higher occurrences of post-procedural AR. TAVI still does not have robust long-term data to ensure its efficacy and rate of complications, but is showing promising results nonetheless.
Literatur
1.
Zurück zum Zitat Lung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Euro Heart J. 2003;24:1231–43.CrossRef Lung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Euro Heart J. 2003;24:1231–43.CrossRef
2.
Zurück zum Zitat ABS 2017. Australian demographic statistics, Jun 2016. ABS cat. no. 3101.0. Canberra: ABS. ABS 2017. Australian demographic statistics, Jun 2016. ABS cat. no. 3101.0. Canberra: ABS.
3.
Zurück zum Zitat Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromsø Study Heart. 2013;99:396–400.PubMed Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromsø Study Heart. 2013;99:396–400.PubMed
4.
Zurück zum Zitat Ben-Dor I, Pichard AD, Gonzalez MA, et.al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation. 2010;122:S37–S42. Ben-Dor I, Pichard AD, Gonzalez MA, et.al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation. 2010;122:S37–S42.
5.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Euro Heart J. 2017;38:2739–91.CrossRef Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Euro Heart J. 2017;38:2739–91.CrossRef
6.
Zurück zum Zitat Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–10.CrossRef Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–10.CrossRef
7.
Zurück zum Zitat Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.CrossRef Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.CrossRef
8.
Zurück zum Zitat Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRef Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRef
9.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRef
10.
Zurück zum Zitat Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
11.
Zurück zum Zitat Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute; 2011. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute; 2011.
12.
Zurück zum Zitat Hirji SA, Ramirez-Del Val F, Kolkailah AA, et al. Outcomes of surgical and transcatheter aortic valve replacement in the octogenarians—surgery still the gold standard? Ann Cardiothorac Surg. 2017;6:453–62.CrossRef Hirji SA, Ramirez-Del Val F, Kolkailah AA, et al. Outcomes of surgical and transcatheter aortic valve replacement in the octogenarians—surgery still the gold standard? Ann Cardiothorac Surg. 2017;6:453–62.CrossRef
13.
Zurück zum Zitat Im E, Hong MK, Ko YG, Shin DH, Kim JS, Kim BK, et al. Comparison of early clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement versus optimal medical therapy in patients older than 80 years with symptomatic severe aortic stenosis. Yonsei Med J. 2013;54:596–602.CrossRef Im E, Hong MK, Ko YG, Shin DH, Kim JS, Kim BK, et al. Comparison of early clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement versus optimal medical therapy in patients older than 80 years with symptomatic severe aortic stenosis. Yonsei Med J. 2013;54:596–602.CrossRef
14.
Zurück zum Zitat Strauch JT, Scherner M, Haldenwang PL, Madershahian N, Pfister R, Kuhn EW, et al. Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians. Thorac Cardiovasc Surg. 2012;60:335–42.CrossRef Strauch JT, Scherner M, Haldenwang PL, Madershahian N, Pfister R, Kuhn EW, et al. Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians. Thorac Cardiovasc Surg. 2012;60:335–42.CrossRef
15.
Zurück zum Zitat Martínez-Sellés M, Gómez Doblas J, Carro Hevia A, García de la Villa B, Ferreira-González I, Alonso Tello A, et al. Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention. J Intern Med. 2014;275:608–20.CrossRef Martínez-Sellés M, Gómez Doblas J, Carro Hevia A, García de la Villa B, Ferreira-González I, Alonso Tello A, et al. Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention. J Intern Med. 2014;275:608–20.CrossRef
16.
Zurück zum Zitat Cao C, Ang S, Indraratna P, Manganas C, Bannon P, Black D, et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg. 2013;2:10–23.PubMedPubMedCentral Cao C, Ang S, Indraratna P, Manganas C, Bannon P, Black D, et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg. 2013;2:10–23.PubMedPubMedCentral
17.
Zurück zum Zitat Indraratna P, Tian DH, Yan TD, Doyle MP, Cao C. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a meta-analysis of randomized controlled trials. Int J Cardiol. 2016;224:382–7.CrossRef Indraratna P, Tian DH, Yan TD, Doyle MP, Cao C. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a meta-analysis of randomized controlled trials. Int J Cardiol. 2016;224:382–7.CrossRef
18.
Zurück zum Zitat Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Euro Heart J. 2012;33:2403–18.CrossRef Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Euro Heart J. 2012;33:2403–18.CrossRef
19.
Zurück zum Zitat Jabbour R, Tanaka A, Colombo A, Latib A. Delayed coronary occlusion after transcatheter aortic valve implantation: implications for new transcatheter heart valve design and patient management. Interv Cardiol. 2018;13:137–9.CrossRef Jabbour R, Tanaka A, Colombo A, Latib A. Delayed coronary occlusion after transcatheter aortic valve implantation: implications for new transcatheter heart valve design and patient management. Interv Cardiol. 2018;13:137–9.CrossRef
20.
Zurück zum Zitat Jorgensen TH, Thygesen JB, Thyregod HG, Svendsen JH, Sondergaard L. New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review. J Invasive Cardiol 2015;27:41–7. Jorgensen TH, Thygesen JB, Thyregod HG, Svendsen JH, Sondergaard L. New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review. J Invasive Cardiol 2015;27:41–7.
21.
Zurück zum Zitat Thiele H. SOLVE-TAVI: self-expanding vs. balloon-expandable valves and local vs. general anesthesia F. Transcatheter Cardiovascular Therapeutics Conference. September 2018, San Diego. Thiele H. SOLVE-TAVI: self-expanding vs. balloon-expandable valves and local vs. general anesthesia F. Transcatheter Cardiovascular Therapeutics Conference. September 2018, San Diego.
22.
Zurück zum Zitat Kumar N, Khera R, Fonarow GC, Bhatt DL. Comparison of outcomes of transfermoral versus transapical approach for transcatheter aortic valve implantation. Am J Cardiol. 2018;122:1520–6.CrossRef Kumar N, Khera R, Fonarow GC, Bhatt DL. Comparison of outcomes of transfermoral versus transapical approach for transcatheter aortic valve implantation. Am J Cardiol. 2018;122:1520–6.CrossRef
Metadaten
Titel
A systematic review and meta-analysis of the clinical outcomes of TAVI versus SAVR in the octogenarian population
verfasst von
Stuart Moss
Mathew Doyle
Vinayak Nagaraja
Sheen Peeceeyen
Publikationsdatum
06.05.2020
Verlag
Springer Singapore
Erschienen in
Indian Journal of Thoracic and Cardiovascular Surgery / Ausgabe 4/2020
Print ISSN: 0970-9134
Elektronische ISSN: 0973-7723
DOI
https://doi.org/10.1007/s12055-019-00912-0

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

Webinar

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" spricht Prof. Dr. Leila Harhaus-Wähner im MedTalk Leitlinie KOMPAKT. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.